Concepts (61)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Uveal Neoplasms | 1 | 2017 | 32 | 0.500 |
Why?
|
| Brachytherapy | 1 | 2017 | 85 | 0.470 |
Why?
|
| Genome, Mitochondrial | 2 | 2011 | 26 | 0.410 |
Why?
|
| DNA, Mitochondrial | 2 | 2011 | 232 | 0.380 |
Why?
|
| Exonucleases | 1 | 2011 | 27 | 0.350 |
Why?
|
| DNA Breaks, Single-Stranded | 1 | 2011 | 19 | 0.340 |
Why?
|
| Melanoma | 1 | 2017 | 927 | 0.300 |
Why?
|
| Mitochondrial Proteins | 1 | 2011 | 283 | 0.300 |
Why?
|
| Apoptosis | 1 | 2011 | 1826 | 0.210 |
Why?
|
| DNA Repair | 3 | 2011 | 568 | 0.180 |
Why?
|
| Antitubercular Agents | 1 | 2020 | 271 | 0.140 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2020 | 848 | 0.130 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2020 | 428 | 0.120 |
Why?
|
| Reactive Oxygen Species | 2 | 2011 | 521 | 0.080 |
Why?
|
| Cell Nucleus | 2 | 2010 | 558 | 0.080 |
Why?
|
| HeLa Cells | 1 | 2011 | 689 | 0.080 |
Why?
|
| Flap Endonucleases | 1 | 2008 | 5 | 0.070 |
Why?
|
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2008 | 13 | 0.070 |
Why?
|
| Mitochondria, Liver | 1 | 2008 | 37 | 0.070 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2008 | 87 | 0.070 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 6763 | 0.060 |
Why?
|
| Wnt1 Protein | 1 | 2005 | 71 | 0.060 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 2005 | 100 | 0.060 |
Why?
|
| Oxidative Stress | 1 | 2010 | 790 | 0.060 |
Why?
|
| DNA Damage | 1 | 2008 | 509 | 0.050 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2005 | 135 | 0.050 |
Why?
|
| Muscle, Skeletal | 1 | 2010 | 980 | 0.050 |
Why?
|
| Aging | 1 | 2010 | 1238 | 0.050 |
Why?
|
| Young Adult | 1 | 2017 | 9978 | 0.050 |
Why?
|
| Agar | 1 | 2020 | 17 | 0.040 |
Why?
|
| Color | 1 | 2020 | 27 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2017 | 12821 | 0.040 |
Why?
|
| Levofloxacin | 1 | 2020 | 49 | 0.040 |
Why?
|
| Isoniazid | 1 | 2020 | 68 | 0.040 |
Why?
|
| Observer Variation | 1 | 2020 | 311 | 0.040 |
Why?
|
| Rifampin | 1 | 2020 | 127 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2011 | 4645 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2005 | 1800 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2017 | 17538 | 0.030 |
Why?
|
| Aged | 1 | 2017 | 20816 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 2 | 2010 | 979 | 0.030 |
Why?
|
| Middle Aged | 1 | 2017 | 28303 | 0.030 |
Why?
|
| Adult | 1 | 2017 | 30999 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 2076 | 0.030 |
Why?
|
| Humans | 3 | 2017 | 130055 | 0.020 |
Why?
|
| Male | 2 | 2017 | 64375 | 0.020 |
Why?
|
| Citrate (si)-Synthase | 1 | 2010 | 17 | 0.020 |
Why?
|
| Female | 1 | 2017 | 70227 | 0.020 |
Why?
|
| Superoxide Dismutase | 1 | 2010 | 173 | 0.020 |
Why?
|
| DNA Polymerase gamma | 1 | 2008 | 19 | 0.020 |
Why?
|
| DNA Polymerase III | 1 | 2008 | 26 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2008 | 435 | 0.020 |
Why?
|
| Mice | 3 | 2010 | 18160 | 0.020 |
Why?
|
| Hyperplasia | 1 | 2005 | 189 | 0.010 |
Why?
|
| Genes, Neoplasm | 1 | 2005 | 80 | 0.010 |
Why?
|
| Animals | 3 | 2010 | 33660 | 0.010 |
Why?
|
| Mammary Glands, Animal | 1 | 2005 | 448 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2008 | 3713 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2005 | 2330 | 0.010 |
Why?
|
| Genotype | 1 | 2005 | 2587 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2005 | 2008 | 0.010 |
Why?
|